SLC5A2 and diabetes mellitus: Meanwhile, a few therapies targeting diabetic mellitus were discovered to increase the possibility of fractures, such as Thiazolidinediones (TZDs) and possibly sodium-glucose cotransporter-2 (SGLT2) (2, 7, 8).